These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20216206)

  • 1. Haemodynamical variables versus endothelial hormones in hypertensive and type 2 diabetic patients with endothelial dysfunction.
    Fouillioux C; Contreras F; Lares M; Magaldi L; Velasco M; La Mayda C; Pacheco B; Rojas J; Chacín M; Cano R; Gotera D; Bermúdez V
    Am J Ther; 2010; 17(3):306-19. PubMed ID: 20216206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and hemodynamic markers of endothelial dysfunction in patients with hypertension and patients with type 2 diabetes during the cold pressor test.
    Fouillioux C; Contreras F; Lares M; Cano R; Leal E; Arraiz N; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):389-96. PubMed ID: 18645344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
    Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
    Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects.
    Contreras F; Fouillioux C; Lares M; Bolívar H; Hernández RH; Velasco M; Cano R; Chacin M; Bermúdez V
    Am J Ther; 2010; 17(3):320-4. PubMed ID: 20216207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients.
    Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H
    Hypertens Res; 2007 Jun; 30(6):541-8. PubMed ID: 17664858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease.
    Cleland SJ; Sattar N; Petrie JR; Forouhi NG; Elliott HL; Connell JM
    Clin Sci (Lond); 2000 May; 98(5):531-5. PubMed ID: 10781383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension.
    Perticone F; Maio R; Sciacqua A; Andreozzi F; Iemma G; Perticone M; Zoccali C; Sesti G
    Diabetes; 2008 Jan; 57(1):167-71. PubMed ID: 17928395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.
    Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B
    Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.
    Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Horio T; Yoshimasa Y; Harano Y
    Am J Hypertens; 2004 Mar; 17(3):228-32. PubMed ID: 15001196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of atherosclerosis markers in salt-sensitive hypertension.
    Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A
    Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of the relationship between remodeling of left ventricle and endothelial injury and pro-inflammatory mediators in different stages of essential hypertension].
    Cai JY; Zhai GL; Gao W; Zhu L; Li Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Dec; 20(12):743-5. PubMed ID: 19111125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
    Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
    Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced sympathoneural responses to the cold pressor test in individuals with essential hypertension and in those genetically predisposed to hypertension. No support for the "pressor reactor" hypothesis of hypertension development.
    Lambert EA; Schlaich MP
    Am J Hypertens; 2004 Oct; 17(10):863-8. PubMed ID: 15485746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
    Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
    Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.